Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Thomas Eleveld

Princess Maxima Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cell Biology Cell Biology professors in Netherlands

Articles (9)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Collaborators (9)

Claire Palles

Associate Professor

University of Birmingham

UNITED KINGDOM

View details

Emanuela Scarpi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

giuseppe schepisi

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

Leendert Looijenga

Group Leader and Managing Director Research, Professor Translational Germ Cell Oncology and Fertility

Princess Maxima Center

NETHERLANDS

View details

Laura Valle

Institut d'Investigacions Biomèdiques de Barcelona

SPAIN

View details

Bauke Ylstra

Director Tumor Genome Analysis Core

Amsterdam University Medical Centers

NETHERLANDS

View details

Andrew Green

Professor of Medical Genetics

Dublin City University

IRELAND

View details

Rogier Versteeg

dept. head

Amsterdam UMC, University of Amsterdam

NETHERLANDS

View details

Daniela Salvatori

Utrecht University

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Eleveld

Research Interests

Explore related searches

Articles (9)

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Yolk Sac Elements in Tumors Derived from Pluripotent Stem Cells: Borrowing Knowledge from Human Germ Cell Tumors

Low-amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilities

Chromosome-specific aberrations, rather than general aneuploidy, may drive mouse embryonic stem cell-derived teratoma metastasis

Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9

Depletion of <i>TP53</i> in Human Pluripotent Stem Cells Triggers Malignant-Like Behavior

Feeder-free culture of human pluripotent stem cells drives MDM4-mediated gain of chromosome 1q

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.

Cytogenetic resource enables mechanistic resolution of changing trends in human pluripotent stem cell aberrations linked to feeder-free culture

Collaborators (9)

Claire Palles

Emanuela Scarpi

giuseppe schepisi

Leendert Looijenga

Laura Valle

Bauke Ylstra

Andrew Green

Rogier Versteeg

Daniela Salvatori

Make your next move.